Translational results bolster confidence as Phase III trial for IMNN-001 in advance epithelial ovarian cancer gets underway.

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Translational Data from OVATION 2 Trial Presented at AACR Special ...

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), , a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announced the publication of the mechanism ...

Imunon (IMNN) announced the presentation of new positive translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational ...

Results from OVATION 2 Study reinforce IMNN-001 efficacy benefits observed in the clinic and unique mechanism of action, producing key ...

Claims that HIV has been permanently eradicated from people living with the virus are false. More research, refined delivery ...

Thus, starting ART soon after diagnosis of HIV infection protects people’s health—it is good fro the user as well as the partner. These findings are likely to affect many countries’ guidelines for ...

People with new-onset type 1 diabetes can achieve similar improvements in C-peptide levels with a 0.5 mg/kg antithymocyte ...

Nigeria’s battle against HIV is faltering as critical diagnostic tests, including resistance testing, CD4 counts, hemoglobin ...

TNF-driven inflammatory arthritis, commonly accompanied by vitamin D deficiency. Here, we investigate the interaction between ...

Researchers evaluated the prevalence of low-level viremia and its influence on the risk for virologic failure in patients with HIV on antiretroviral therapy.

Type 1 diabetes remains a persistent health-care burden despite substantial advances in care. Its preclinical disease course ...